TrialEuropean journal of endocrinology2017

MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults.

Christian J Strasburger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.